Figure 3.
Cumulative incidence (%) of posttransplant lymphoproliferative disorders (PTLD) and invasive solid cancers following allogeneic marrow transplantation at 235 centers worldwide.
Reproduced with permission from Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208-2216.